Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Braz. j. infect. dis ; 14(2): 158-166, Mar.-Apr. 2010. ilus, tab
Artigo em Inglês | LILACS | ID: lil-548461

RESUMO

OBJECTIVE: Determine the prevalence of metabolic abnormalities (MA) and estimate the 10-year risk for cardiovascular disease (CVD) among Latin American HIV-infected patients receiving highly active anti-retroviral therapy (HAART). METHODS: A cohort study to evaluate MA and treatment practices to reduce CVD has been conducted in seven Latin American countries. Adult HIV-infected patients with at least one month of HAART were enrolled. Baseline data are presented in this analysis. RESULTS: A total of 4,010 patients were enrolled. Mean age (SD) was 41.9 (10) years; median duration of HAART was 35 (IQR: 10-51) months, 44 percent received protease inhibitors. The prevalence of dyslipidemia and metabolic syndrome was 80.2 percent and 20.2 percent, respectively. The overall 10-year risk of CVD, as measured by the Framingham risk score (FRF), was 10.4 (24.7). Longer exposure to HAART was documented in patients with dyslipidemia, metabolic syndrome and type 2 diabetes mellitus. The FRF score increased with duration of HAART. Male patients had more dyslipidemia, high blood pressure, smoking habit and higher 10-year CVD than females. CONCLUSIONS: Traditional risk factors for CVD are prevalent in this setting leading to intermediate 10-year risk of CVD. Modification of these risk factors through education and intervention programs are needed to reduce CVD.


Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fármacos Anti-HIV/efeitos adversos , Terapia Antirretroviral de Alta Atividade/efeitos adversos , Doenças Cardiovasculares/induzido quimicamente , Infecções por HIV/tratamento farmacológico , Doenças Metabólicas/induzido quimicamente , Estudos de Coortes , /induzido quimicamente , Dislipidemias/induzido quimicamente , Infecções por HIV/sangue , Infecções por HIV/complicações , América Latina , Síndrome Metabólica/induzido quimicamente , Fatores de Risco
2.
Centro méd ; 41(2): 47-50, nov. 1996. ilus
Artigo em Espanhol | LILACS | ID: lil-259328

RESUMO

La Dermatomiositis Juvenil es una enfermedad inflamatoria y degenerativa del músculo estriado capaz de ocasionar errores diagnósticos y tratamientos inadecuados, debido a que su baja incidencia conduce a una falta de conocimiento entre los médicos. Presentamos un caso, ocurrido en el Hospital Privado Centro Médico de Caracas en Febrero de 1966, en un adolescente de 13 años con un cuadro clínico característico, pero con cifras alarmantes de creatininquinasa. La respuesta terapéutica fue excelente


Assuntos
Humanos , Masculino , Adolescente , Creatinina/administração & dosagem , Creatinina/imunologia , Dermatomiosite/diagnóstico , Pleurodinia Epidêmica/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA